Global Precision Medicine Market 2020 Size and Growth Factors Research and Projection || Leading Players –Neon Therapeutics, Moderna, Inc, Merck & Co., Inc, Bayer AG, PERSONALIS INC

Data Bridge Market Research has recently added a concise research on the Global Precision Medicine Market to depict valuable insights related to significant market trends driving the industry. The Global Precision Medicine Market report makes available the basic information about industry, definition, classification, application, industry chain structure, industry overview and international market analysis. As per this report, the market is expected to grow at a substantial Compound Annual Growth Rate (CAGR) during the forecast period 2020-2027. This market document provide the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios. It also gives widespread study about different market segments and regions. The Global Precision Medicine Market underlines the global key manufacturers, to define, describe and analyze the market competition landscape with the help of SWOT analysis.

Global Precision Medicine Market to grow with a substantial CAGR in the forecast period of 2019-2026. Growing prevalence of cancer worldwide and accelerating demand of novel therapies to prevent of cancer related disorders are the key factors for lucrative growth of market

Key Market Players:

Few of the major competitors currently working in the global precision medicine market are Neon Therapeutics, Moderna, Inc, Merck & Co., Inc, Bayer AG, PERSONALIS INC, GENOCEA BIOSCIENCES, INC., F. Hoffmann-La Roche Ltd, CureVac AG, CELLDEX THERAPEUTICS, BIONTECH SE, Advaxis, Inc, GlaxoSmithKline plc, Bioven International Sdn Bhd, Agenus Inc., Immatics Biotechnologies GmbH, Immunovative Therapies, Bristol-Myers Squibb Company, Gritstone Oncology, NantKwest, Inc among others.

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @
http://databridgemarketresearch.com/request-a-sample/?dbmr=global-precision-medicine-market

The market data analysed and evaluated in the world class Precision Medicine Market report makes to achieve the business goals and objectives in preset time frame. This market research report endows with productive ideas which in turn help to make the product more effective and striking in the competitive market. This report covers the specific study of the industry which explains what the market definition, classifications, applications, engagements, and global industry trends are. The Global Precision Medicine Market research report takes into account key product developments and tracks recent acquisitions, mergers and research in the industry by the key market players.

Global Precision Medicine Market By Application (Diagnostics, Therapeutics and Others), Technologies (Pharmacogenomics, Point-of-Care Testing, Stem Cell Therapy, Pharmacoproteomics and Others), Indication (Oncology, Central Nervous System (CNS) Disorders, Immunology Disorders, Respiratory Disorders, Others), Drugs (Alectinib, Osimertinib, Mepolizumab,Aripiprazole lauroxil and Others), Route of Administration (Oral,Injectable), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Key Developments in the Market:

• In March 2019, Neon Therapeutics, Inc. reported the data for NEO-PV-01, a novel personalized cancer vaccine to be developed in a combination with nivolumab that targeting neoantigens and kills cancer cells that trial demonstrated clinical benefits. The NEO-PV-01 is currently in phase I/II clinical trial, if successful it will provide patients with more effective personalized medicines treatment options
• In September 2016, BioNTech AG and Genentech, Inc. has entered into research collaboration for the development of messenger RNA (mRNA)-based, individualized cancer vaccines for the treatment of broad range of cancer. As per the deal, BioNTech AG received USD 310 million as an upfront payment and eligible to receive milestone payment. This collaboration will provide cancer patients with novel-disease specific treatment options

Competitive Analysis:

The precision medicine market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of mass spectrometry market for global, Europe, North America, Asia Pacific and South America.

Market Drivers

• Vulnerable oncology patients worldwide is driving the market growth
• Growing approval of personalized medicines from the regulatory authorities acts as a market driver
• Advancing in the field and emerging innovation to established an approach for treating many disease by personalized medicines is accelerating the market growth
• On-going clinical trials yields promising results of personalized medicines which in turns boost the health care industries is also enhancing the market growth

Market Restraints

• Substantial applications due to lack of research particularly in the area of scientific discovery is restraining the growth of this market
• Lack of government initiatives and reimbursement polices restricts the market growth
• Scientific and technological challenges to develop the personalized medicines is also hampering the market growth

For More Insights Get FREE Detailed TOC @
https://www.databridgemarketresearch.com/toc/?dbmr=global-precision-medicine-market

Market Definition:

Precision medicines is also known as personalized medicines is an innovative approach to the patient care for disease treatment, diagnosis and prevention base on the person’s individual genes. It allows doctors or physicians to select treatment option based on the patient’s genetic understanding of their disease.

According to the data published in PerMedCoalition, it was estimated that the USFDA has approved 25 novels personalized medicines in the year of 2018. These growing approvals annually by the regulatory authorities and rise in oncology and CNS disorders worldwide are the key factors for market growth.

Grab Your Report at an Impressive 30%  Discount! Please click Here@https://www.databridgemarketresearch.com/request-a-discount/global-precision-medicine-market

Key Developments in the Market:

• In March 2019, Neon Therapeutics, Inc. reported the data for NEO-PV-01, a novel personalized cancer vaccine to be developed in a combination with nivolumab that targeting neoantigens and kills cancer cells that trial demonstrated clinical benefits. The NEO-PV-01 is currently in phase I/II clinical trial, if successful it will provide patients with more effective personalized medicines treatment options
• In September 2016, BioNTech AG and Genentech, Inc. has entered into research collaboration for the development of messenger RNA (mRNA)-based, individualized cancer vaccines for the treatment of broad range of cancer. As per the deal, BioNTech AG received USD 310 million as an upfront payment and eligible to receive milestone payment. This collaboration will provide cancer patients with novel-disease specific treatment options

Competitive Analysis:

Global precision medicine market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global precision medicine market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Segmentation: Global Precision Medicine Market

By Application

• Diagnostics
• Therapeutics
• Others

By Technologies

• Pharmacogenomics
• Point-of-Care Testing
• Stem Cell Therapy
• Pharmacoproteomics
• Others

By Indication

• Oncology
• Central Nervous System (CNS) Disorders
• Immunology Disorders
• Respiratory Disorders
• Others

By Drugs

• Alectinib
• Osimertinib
• Mepolizumab
• Aripiprazole lauroxil
• Others

By Route of Administration

• Oral
• Injectable

 By End Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.